FW: Life Science companies / Gates

Larry & Boris,

I'm following-up on my conversation with Larry about potential life science=companies to meet next Friday.

We can meet with Trius for an update. You helped put them on a good path af=er our last meeting, but they've hit a few roadblocks. We think it's worth=a follow-up.

The other companies suggested - Calixa, Novadyne, Alphavax - are more matur= and/or we've exited. In other words, we aren't actively engaged in these =ompanies.

I've copied Risa Stack, one of our Life Science partners who you met in May=with Trius. She's pulling together a list of current companies to see if t=ere is 1-2 others you might be interested in. Boris -we previously passed =n meeting 3V BioSciences. We met with PacBio the day of their IPO in 2010.=We don't have many other therapeutic related investments.

Thanks for your guidance.

-lila

Thank you Lila!

How about Foundation Medicine?

Trius might be interesting as there are few issues that Foundation is tryin= to resolve.

Thank you

Boris

Boris-

The CEO of Trius Jeff Stein would very much like to connect with you tadn i= optimistic that we can work together to resolve issues so we can move for=ard with a relationship.

Foundation Medicine is a great idea; the CEO Mike Pellini will be there! I =ill get you a full list of active life sciences companies in a few hours a=d more information on Foundation Medicine.

Looking forward to seeing you next week.

Risa

Risa Stack, Ph.D.
Partner
Kleiner Perkins Caufield & Byers
2750 Sand Hill Road
Menlo Park, CA 94025
Assistant
Barbara Bell

Below is an email (middle one) in which I requested that we included Founda=ion Medicine - which was not included in the list of company KPBC wanted t= present to Bill,

After I suggested that FM gets included KPBC agreed (email just below).

Even after that it took me several emails more as Foundation Medicine got o=itted. Will send you those.

Boris